Latest filing: Analysts/Institutional Investor Meet/Con. Call Updates - Divi's Laboratories Limited
ObservedCompany dossier
Divis Laboratories
NSE:DIVISLAB · ISIN INE361B01024
- Close
- ₹7,784.5 29 Jul 2026
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Divis Laboratories
Overview
Evidence state
Coverage in progressCompany record at a glance
Latest reported period: 31 Mar 2026 · revenue ₹2,831 Cr · PAT ₹751 Cr.
Exchange XBRLLatest ownership: promoter group 51.88% and public 48.12% as of 30 Jun 2026.
Exchange XBRLMaterial events
Open timeline →What changed recently
Observed
Source filing Analysts/Institutional Investor Meet/Con. Call Updates - Divi's Laboratories Limited
NSE · conference call
Observed
Source filing Divis Laboratories Ltd - 532488 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
BSE · conference call
Observed
Source filing Divis Laboratories Ltd - 532488 - Board Meeting Intimation for Considering And Approving The Unaudited Financial Results Of The Company For The Quarter Ended June 30, 2026.
BSE · financial results
Observed
Source filing Divis Laboratories Ltd - 532488 - Announcement under Regulation 30 (LODR)-Newspaper Publication
BSE · exchange filing
Reported financials
Full financials →31 Mar 2026
- Revenue from operations
- ₹2,831 Cr
- Profit after tax
- ₹751 Cr
- EPS
- ₹28.31
Observed BSE structured filing · consolidated
Ownership
Full shareholding →30 Jun 2026
- Promoter group
- 51.88%
- Public
- 48.12%
- Employee trust
- 0.00%
Observed NSE shareholding XBRL